Deoxyguanosine is a TLR7 agonist

Deoxyguanosine is a TLR7 agonist

Toll-like receptor 7 (TLR7) is an innate immune sensor for single-strand RNA (ssRNA). Recent structural analysis revealed that TLR7 has an additional binding site for nucleosides such as guanosine and is activated when both guanosine and ssRNA bind. The nucleoside binding site also accommodates imid...

Detaylı Bibliyografya
Asıl Yazarlar:	Davenne, T, Bridgeman, A, Rigby, R, Rehwinkel, J
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	Wiley 2019

Benzer Materyaller

Comparison of human B cell activation by TLR7 and TLR9 agonists
Yazar:: Neys Lori, ve diğerleri
Baskı/Yayın Bilgisi: (2008-07-01)

The role of TLR7 agonists in modulating COVID-19 severity in subjects with loss-of-function TLR7 variants
Yazar:: Shaik Mohammad Naushad, ve diğerleri
Baskı/Yayın Bilgisi: (2023-08-01)

Potent adjuvanticity of a pure TLR7-agonistic imidazoquinoline dendrimer.
Yazar:: Nikunj M Shukla, ve diğerleri
Baskı/Yayın Bilgisi: (2012-01-01)

Molecular dynamics simulations reveal the selectivity mechanism of structurally similar agonists to TLR7 and TLR8.
Yazar:: Xiaoyu Wang, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

The TLR7 agonist Imiquimod promote the immunogenicity of msenchymal stem cells
Yazar:: Li Zhang, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01)

PNP inhibitors selectively kill cancer cells lacking SAMHD1
Yazar:: Tamara Davenne, ve diğerleri
Baskı/Yayın Bilgisi: (2020-11-01)

BBIQ, a pure TLR7 agonist, is an effective influenza vaccine adjuvant
Yazar:: Deepender Kaushik, ve diğerleri
Baskı/Yayın Bilgisi: (2020-08-01)

Transcriptional networks in plasmacytoid dendritic cells stimulated with synthetic TLR 7 agonists
Yazar:: Vasilakos John P, ve diğerleri
Baskı/Yayın Bilgisi: (2007-10-01)

Alum and a TLR7 agonist combined with built-in TLR4 and 5 agonists synergistically enhance immune responses against HPV RG1 epitope
Yazar:: Maryam Mashhadi Abolghasem Shirazi, ve diğerleri
Baskı/Yayın Bilgisi: (2023-10-01)

Varicella-Zoster virus ORF9 Is an antagonist of the DNA sensor cGAS
Yazar:: Hertzog, J, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Determining 8-oxo-2’-deoxyguanosine/2’-deoxyguanosine ratio in DNA by reverse phase HPLC combined with amperometric detection
Yazar:: D. S. Esipov, ve diğerleri
Baskı/Yayın Bilgisi: (2010-06-01)

Synthesis of 8-oxo-7,8-dihydro-2′-deoxyguanosine from 2′-deoxyguanosine using Cu(II)/H2O2/ascorbate: A new strategy for an improved yield
Yazar:: Patrícia S. Peres, ve diğerleri
Baskı/Yayın Bilgisi: (2016-06-01)

Genomic 8-oxo-7,8-dihydro-2&#39;-deoxyguanosine Quantification
Yazar:: Antonio Sarno
Baskı/Yayın Bilgisi: (2013-09-01)

Interferon induction held captive in tumor cells
Yazar:: Bridgeman, A, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Innate immune receptors in human airway smooth muscle cells: activation by TLR1/2, TLR3, TLR4, TLR7 and NOD1 agonists.
Yazar:: Anne Månsson Kvarnhammar, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

NOD2 Agonist Promotes the Production of Inflammatory Cytokines in VSMC in Synergy with TLR2 and TLR4 Agonists
Yazar:: Jinghua Sun, ve diğerleri
Baskı/Yayın Bilgisi: (2012-01-01)

Electrophilic Substitution at C(7) of a Protected 7-Deaza-2’-deoxyguanosine – The 2’-Deoxyribonucleoside Parent Analogue of Queuosine #
Yazar:: Helmut Rosemeyer, ve diğerleri
Baskı/Yayın Bilgisi: (2007-04-01)

Lignin-chitosan-based biocomposite film for the localized delivery of TLR7 agonist imiquimod
Yazar:: Aashna Jassal, ve diğerleri
Baskı/Yayın Bilgisi: (2024-11-01)

ProLonged Liposomal Delivery of TLR7/8 Agonist for Enhanced Cancer Vaccine
Yazar:: Sehui Kim, ve diğerleri
Baskı/Yayın Bilgisi: (2023-09-01)

A Therapeutic Whole-Tumor-Cell Vaccine Covalently Conjugated with a TLR7 Agonist
Yazar:: Huju Chi, ve diğerleri
Baskı/Yayın Bilgisi: (2022-06-01)

8-Oxo-7,8-Dihydro-2′-Deoxyguanosine (8-oxodG) and 8-Hydroxy-2′-Deoxyguanosine (8-OHdG) as a Potential Biomarker for Gestational Diabetes Mellitus (GDM) Development
Yazar:: Sandra K. Urbaniak, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)

Varicella‐Zoster virus ORF9 is an antagonist of the DNA sensor cGAS
Yazar:: Hertzog, J, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Viruses transfer the antiviral second messenger cGAMP between cells
Yazar:: Bridgeman, A, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

Immunogenicity in humans of a transdermal multipeptide melanoma vaccine administered with or without a TLR7 agonist
Yazar:: Craig L Slingluff, ve diğerleri
Baskı/Yayın Bilgisi: (2021-05-01)

A TLR7/8 agonist increases efficacy of anti-fentanyl vaccines in rodent and porcine models
Yazar:: Bethany Crouse, ve diğerleri
Baskı/Yayın Bilgisi: (2023-07-01)

T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles
Yazar:: Verena Turco, ve diğerleri
Baskı/Yayın Bilgisi: (2023-02-01)

Biotinylation of Deoxyguanosine at the Abasic Site in Double-Stranded Oligodeoxynucleotides
Yazar:: Chun Wu
Baskı/Yayın Bilgisi: (2016-01-01)

Mitochondrial deoxyguanosine kinase is required for female fertility in mice
Yazar:: Gao Yake, ve diğerleri
Baskı/Yayın Bilgisi: (2024-02-01)

1161 Development of TLR7- and STING-conjugatable agonists for immunostimulatory ADC-based cancer therapies
Yazar:: Fabienne Vernejoul, ve diğerleri
Baskı/Yayın Bilgisi: (2023-11-01)

8-Oxo-2’-deoxyguanosine – biomarker of the oxidative stress
Yazar:: T. S. Nevredimova, ve diğerleri
Baskı/Yayın Bilgisi: (2014-10-01)

Sequence-Dependent Variation in the Reactivity of 8-Oxo-7,8-dihydro-2′-deoxyguanosine toward Oxidation
Yazar:: Lim, Kok Seong, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Formulated Phospholipids as Non-Canonical TLR4 Agonists
Yazar:: Hong Liang, ve diğerleri
Baskı/Yayın Bilgisi: (2022-11-01)

The mechanism of decomposition of N-methyl-N-nitrosourea (MNU) in water and a study of its reactions with 2'-deoxyguanosine, 2'-deoxyguanosine 5'-monophosphate and d(GTGCAC)
Yazar:: Golding, B, ve diğerleri
Baskı/Yayın Bilgisi: (1997)

Deoxyguanosine kinase deficiency: natural history and liver transplant outcome
Yazar:: Manzoni, E, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Employing Drug Delivery Strategies to Overcome Challenges Using TLR7/8 Agonists for Cancer Immunotherapy
Yazar:: Varshney, Dhruv, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Employing Drug Delivery Strategies to Overcome Challenges Using TLR7/8 Agonists for Cancer Immunotherapy
Yazar:: Varshney, Dhruv, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Safety, tolerability, pharmacokinetics, and pharmacodynamics of a TLR7 agonist prodrug RO6870868 in healthy volunteers
Yazar:: Joseph F. Grippo, ve diğerleri
Baskı/Yayın Bilgisi: (2021-07-01)

Identifying the Tautomeric Form of a Deoxyguanosine-Estrogen Quinone Intermediate
Yazar:: Douglas E. Stack
Baskı/Yayın Bilgisi: (2015-09-01)

Atherosclerosis induced by endogenous and exogenous toll-like receptor (TLR)1 or TLR6 agonists
Yazar:: Linda K. Curtiss, ve diğerleri
Baskı/Yayın Bilgisi: (2012-10-01)

The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer
Yazar:: Katherine A. Michaelis, ve diğerleri
Baskı/Yayın Bilgisi: (2019-10-01)